Play

A treatment known as convalescent plasma, which is basically antibodies from someone who’s already recovered from COVID, can help in early COVID infection, but the caveat is early. Arturo Casadevall, a convalescent plasma expert at Johns Hopkins, says for people …

If you’re infected with COVID when should you seek medical care? Elizabeth Tracey reports Read more »

Play

Antibodies in the blood of people who’ve had COVID and recovered can help others avoid severe cases of the disease, use of this treatment in some has shown. Yet when larger scale clinical trials were undertaken, results were largely lackluster, …

Why don’t clinical trials provide support for convalescent plasma therapy for COVID? Elizabeth Tracey reports Read more »

Play

Convalescent plasma is plasma donated by people who’ve already had COVID and recovered. Early in the pandemic this historically successful technique was attempted to stem the tide of COVID-related death, but now the therapy has fallen into disuse. Arturo Casadevall, …

Plasma from people who’ve had COVID is underutilized as a treatment, Elizabeth Tracey reports Read more »

Play

In this next podcast, Elizabeth Scala and Maddie Whalen discuss a topic that’s specific to Evidence-Based Practice projects which is the difference between a background question and a foreground question. Maddie discusses a project that she helped staff with and …

Ep28 Background vs Foreground | Center for Nursing Inquiry Read more »

Play

Remote monitoring helps people undergoing treatment for cancer cope better with emerging symptoms, a new study concludes. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says this strategy may be even more important as new cancer treatments …

Remote monitoring of people undergoing treatment for cancer may be especially useful with newer therapies, Elizabeth Tracey reports Read more »

Play

People who used a remote monitoring tool to report daily symptoms as they underwent cancer treatment did better with regard to managing their treatment than those who did not, a new study finds. William Nelson, director of the Kimmel Cancer …

What’s the impact of remote monitoring for people being treated for cancer? Elizabeth Tracey reports Read more »

Play

People who are 75 and older and otherwise healthy reap benefits from continuing colorectal cancer screening, a new study found. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says that with new fecal screening tests, such a …

If you choose to continue colorectal cancer screening after you’ve turned 75, which test is best? Elizabeth Tracey reports Read more »